Xavier Leleu
Impact in
- Hematology top 0.05%
- Multiple Myeloma Research and Treatments
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 337
- Multiple Myeloma Research and Treatments 291
- Chronic Myeloid Leukemia Treatments 34
- Genetics 177
- Chronic Lymphocytic Leukemia Research 155
- Co-authors
- Philippe MoreauThierry FaçonIrene M. GhobrialJean‐Luc HarousseauAldo M. RoccaroHervé Avet‐LoiseauMeletios Α. DimopoulosAntonio Sacco
- Journals
- Blood (146 papers)Journal of Clinical Oncology (46 papers)Clinical Cancer Research (17 papers)HemaSphere (17 papers)Leukemia (11 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Xavier Leleu
421 papers receiving 11.2k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Hematology 6.9k
- Genetics 3.0k
- Oncology 4.4k
- Pathology and Forensic Medicine 2.1k
- Molecular Biology 6.4k
Countries citing papers authored by Xavier Leleu
This map shows the geographic impact of Xavier Leleu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Leleu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Leleu more than expected).
Fields of papers citing papers by Xavier Leleu
This network shows the impact of papers produced by Xavier Leleu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Leleu. The network helps show where Xavier Leleu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xavier Leleu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 28 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 2 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 5 | |
| 11 | 2020 | 24 | |
| 12 | 2020 | 53 | |
| 13 | 2018 | 20 | |
| 14 | 2017 | 62 | |
| 15 | 2015 | 82 | |
| 16 | Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus. | 2014 | 0 |
| 17 | 2011 | 36 | |
| 18 | 2010 | 96 | |
| 19 | 2010 | 298 | |
| 20 | 2009 | 15 |
About Xavier Leleu
Xavier Leleu is a scholar working on Hematology, Genetics, Oncology, Pathology and Forensic Medicine and Molecular Biology, having authored 457 papers that have together received 11.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (291 papers), Chronic Lymphocytic Leukemia Research (155 papers), Protein Degradation and Inhibitors (114 papers), Peptidase Inhibition and Analysis (76 papers), Lymphoma Diagnosis and Treatment (75 papers), Cancer Treatment and Pharmacology (53 papers), Chronic Myeloid Leukemia Treatments (34 papers) and Immunodeficiency and Autoimmune Disorders (31 papers). The work is most often cited by research in Hematology (6.9k citations), Genetics (3.0k citations), Oncology (4.4k citations), Pathology and Forensic Medicine (2.1k citations) and Molecular Biology (6.4k citations). Xavier Leleu has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Philippe Moreau, Thierry Façon, Irene M. Ghobrial, Jean‐Luc Harousseau, Aldo M. Roccaro, Hervé Avet‐Loiseau, Meletios Α. Dimopoulos, Antonio Sacco, Salomon Manier and Kenneth C. Anderson. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, HemaSphere and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.